ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 24 filers reported holding ACHILLES THERAPEUTICS PLC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $119,310 | +76.0% | 95,445 | +25.1% | 0.06% | +75.8% |
| Q4 2023 | $67,805 | -4.7% | 76,269 | -2.4% | 0.03% | -17.5% |
| Q3 2023 | $71,126 | +0.6% | 78,169 | +4.5% | 0.04% | 0.0% |
| Q2 2023 | $70,673 | -2.4% | 74,769 | -1.1% | 0.04% | +8.1% |
| Q1 2023 | $72,415 | +163.6% | 75,625 | +147.7% | 0.04% | +146.7% |
| Q4 2022 | $27,473 | -61.8% | 30,525 | -5.2% | 0.02% | -60.5% |
| Q3 2022 | $72,000 | – | 32,200 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $9,035,831 | 10.52% |
| BML Capital Management, LLC | 625,174 | $509,517 | 0.36% |
| FCPM III SERVICES B.V. | 2,390,050 | $1,947,891 | 0.29% |
| Ikarian Capital, LLC | 1,443,181 | $1,176,193 | 0.20% |
| Vestal Point Capital, LP | 1,500,000 | $1,222,500 | 0.09% |
| Redmile Group, LLC | 1,608,089 | $1,310,593 | 0.08% |
| Artal Group S.A. | 755,375 | $615,631 | 0.02% |
| Baker Brothers Advisors | 1,108,767 | $903,645 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 420,481 | $342,692 | 0.01% |
| XTX Topco Ltd | 51,660 | $42,103 | 0.00% |